Big Pharma Shakeup: Neurocrine Buys Soleno for Breakthrough Hunger Drug
Neurocrine’s $2.9 Billion Bet: A Strategic Move Into Rare Diseases In a…
One Year After Trump’s Tariffs: Winners, Losers, and What Changed Forever
One Year Later: How Trump’s Tariffs Changed Business in America It’s been…
$170 Billion Patent Cliff Pushes Global Pharma into Renewed Biotech Buying Spree
Global pharmaceutical giants are accelerating efforts to acquire biotech companies and late-stage…
This Shocking Breakthrough Just Made Eli Lilly a Trillion-Dollar Monster
A company built on diabetes treatments just did the unthinkable. Eli Lilly,…
Boardroom Shockwave: Novo Nordisk Plunges Into Chaos as Power Struggle Explodes
Novo Nordisk Just Entered Crisis Mode A corporate earthquake has erupted inside…